ZzzQuil is an over-the-counter medication utilized most frequently to enhance sleep quality among individuals with allergies or the “common cold.” However, because ZzzQuil is a potent sleep aid, individuals without health problems sometimes use the medication to help manage insomnia. On occasion, ZzzQuil is even administered for the treatment of motion sickness and extrapyramidal symptoms …
ZzzQuil is an over-the-counter (OTC) sleep aid manufactured by Vicks (a subsidiary of Proctor & Gamble) that initially hit the market in 2012. When administered on an “as-needed” basis, ZzzQuil is thought to alleviate occasional bouts of insomnia and other sleep disturbances with minimal risk of abuse, addiction, and/or dependence – as compared to pharmaceutical …
Zomig (Zolmitriptan) is a medication marketed by AstraZeneca and is FDA-approved as an abortive therapy for migraines and cluster headaches. Chemically, it’s classified as a triptan implying that it’s a tryptamine-derivative, and is manufactured in multiple formats including: tablet and nasal spray. Similar to other triptans, Zomig is considered efficacious when administered during a migraine …
Maxalt (Rizatriptan) is a pharmaceutical medication engineered by Merck & Co. for the treatment of migraine headaches (with or without aura). It received FDA approval in 1998 as an abortive antimigraine intervention and is chemically classified as a second-generation triptan (tryptamine-based). Analogous to other triptans, Rizatriptan remains ineffective as a migraine prophylactic, however, it is …
Relpax (Eletriptan) is a medication manufactured by Pfizer Inc. for the acute treatment of migraine headaches (with or without aura) in adults. It was initially approved by the FDA in 2002 and is regarded as a highly effective abortive agent, engineered to attenuate already-occurring migraine attacks. Chemically, Relpax is classified as a second generation triptan …
Sumatriptan (brand names “Imitrex”) is a synthetic medication that was initially approved in 1991 for the treatment of migraine and cluster headaches. Chemically, it is classified as a “triptan” or tryptamine-based agent and is identified as a structural analogue of various alkaloids such as bufotenine and DMT (dimethyltryptamine). When administered following the onset of a …
Mirapex (Pramipexole) is a medication that was approved by the FDA in 1997 for the treatment of idiopathic (early-stage and advanced) Parkinson’s disease. Analysis of the drug’s pharmacodynamics reveals its function as a mixed partial/full dopamine agonist, with highest affinity for: D3 receptors, D2 receptors (D2S and D2L), and D4 receptors (in that order). To …